More recently, it has been shown that inhibition of CPT1 and fatty acid oxidation reduces the activation of the proto-oncogene SRC, including mitochondrially-localized SRC, to result in reduced in vitro and in vivo triple-negative breast cancer cell and tumor growth [287]. This evidence concerns the gene CPT2 and neoplasm.